Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Operating Loss Carryforwards in CNY from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2019 to Q4 2023.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was ¥218M, a 19.6% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (CNY)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 218M +35.7M +19.6% Dec 31, 2023 20-F 2024-04-29
Q4 2022 182M +84.2M +85.9% Dec 31, 2022 20-F 2024-04-29
Q4 2021 98M +37.7M +62.6% Dec 31, 2021 20-F 2023-04-20
Q4 2020 60.3M +7.7M +14.6% Dec 31, 2020 20-F 2022-04-29
Q4 2019 52.6M Dec 31, 2019 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.